Nondisclosure of HIV Infection to Sex Partners and Alcohol’s Role: A Russian Experience

Lunze, Karsten; Cheng, Debbie M.; Quinn, Emily; Krupitsky, Evgeny; Raj, Anita; Walley, Alexander Y.; Bridden, Carly; Chaisson, Christine E.; Lioznov, Dmitry; Blokhina, Elena; Samet, Jeffrey H.

doi:10.1007/s10461-012-0216-z

Cited by 21 publications

(15 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We analyzed data from a cohort of 700 HIV-infected participants in the H IV's Evolution in Russia - Mitigating Infection Transmission and Alcoholism in a Growing Epidemic (HERMITAGE) randomized controlled trial conducted between 2007 and 2011 in St. Petersburg, Russian Federation (Lunze et al, 2012). The main eligibility criteria included the following: HIV-infection; 18-70 years old; any risky drinking by National Institute on Alcohol Abuse and Alcoholism (NIAAA) criteria in the past 6 months (National Institute on Alcohol Abuse and Alcoholism, 2007) and unprotected vaginal or anal sex in the past 6 months.…”

Section: Methodsmentioning

confidence: 99%

Is cannabis use associated with HIV drug and sex risk behaviors among Russian HIV-infected risky drinkers?

Tyurina¹,

Krupitsky²,

Cheng³

et al. 2013

Drug and Alcohol Dependence

Self Cite

View full text Add to dashboard Cite

Background While cannabis use has been associated with increased HIV drug and sex risk behaviors, its impact on risk behaviors among HIV-infected individuals has not yet been established. Methods This study examined data from Russian HIV-infected risky drinkers enrolled in a randomized controlled trial of a behavioral intervention. The primary independent variable was cannabis use (current [past 30 days use], recent past [use but not in past 30 days] vs. no past year use). Primary outcomes were needle sharing and number of unprotected sexual episodes. Secondary outcomes were drug injection, number of injections, and multiple sex partners. Longitudinal regression analyses controlled for age, gender, marital status, education, CD4 count, ART use, risky alcohol use, other drug use, depressive symptoms and randomization group. Results Cannabis use was common with 20% current and 26% recent past use at baseline. In longitudinal analyses current, but not recent past, cannabis consumption was significantly associated with needle sharing (AOR 2.23 current vs. none, 95% CI: 1.46, 3.36), drug injection (AOR 3.05 current vs. none, 95% CI: 2.06, 4.53) and number of injections (adjusted IRR 1.50 current vs. none, 95% CI: 1.19, 1.89). Current and recent past cannabis use were significantly associated with multiple sex partners but not with number of unprotected sex episodes. Conclusion Cannabis use was associated with drug and sex risk behaviors among Russian HIV-infected risky drinkers. Inquiry about cannabis use among HIV-infected patients may reveal a patient group at higher risk for sex and drug use behaviors that lead to HIV transmission.

show abstract

Section: Methodsmentioning

confidence: 99%

Is cannabis use associated with HIV drug and sex risk behaviors among Russian HIV-infected risky drinkers?

Tyurina¹,

Krupitsky²,

Cheng³

et al. 2013

Drug and Alcohol Dependence

Self Cite

View full text Add to dashboard Cite

show abstract

“…[19]. As a consequence of anticipated and experienced stigma, people living with HIV (PLWH) often choose not to disclose their status to others (e.g., to their employer, health service providers, family, or sex partners) [20, 21]. A UNAIDS report estimated that 10% of PLWH in Russia were denied health services, 5% denied family planning services, and 3% were denied employment [22], indicating that stigma might contribute to the marginalization of PLWH.…”

Section: Introductionmentioning

confidence: 99%

HIV Stigma and Unhealthy Alcohol Use Among People Living with HIV in Russia

et al. 2017

Self Cite

View full text Add to dashboard Cite

Unhealthy alcohol use, highly prevalent in the Russian Federation (Russia), is associated with HIV risk behaviors among people living with HIV (PLWH). HIV stigma contributes to the HIV risk environment in Russia. To examine HIV stigma among Russian PLWH and to explore its association with unhealthy alcohol use, we conducted a longitudinal analysis of 700 PLWH in St. Petersburg, Russia. We assessed the association between alcohol dependence and HIV stigma measured at baseline and 12 months follow-up. Participants with alcohol dependence (n = 446) reported significantly higher HIV stigma scores over time than those without dependence (n = 254) (adjusted mean difference 0.60, 95% CI 0.03–1.17; p = 0.04). In secondary analyses, we examined recent risky alcohol use and did not detect an association with HIV stigma. Alcohol dependence is associated with high HIV stigma among Russian PLWH but the nature of the association is conjectural. HIV prevention efforts in Russia that address alcohol use disorders hold potential to mitigate HIV-related stigma and its possible adverse effects among PLWH.

show abstract

“…Such nondisclosure was common in the HERMITAGE study participants. 43 Nondisclosure is an individual characteristic that may well identify individuals who have ambivalence about their diagnosis and willingness to acknowledge the HIV diagnosis in a variety of spheres of life. Accordingly, disclosure of HIV infection to sexual partners and social networks is associated with safer sex behaviors, 44 retention in HIV care, 45 patient adherence to antiretroviral treatment, and health service utilization in general.…”

Section: Discussionmentioning

confidence: 99%

Factors Associated With Study Attrition Among HIV-Infected Risky Drinkers in St. Petersburg, Russia

Kiriazova

Cheng

Coleman

et al. 2014

HIV Clinical Trials

View full text Add to dashboard Cite

Background Participant attrition in HIV longitudinal studies may introduce bias and diminish research quality. The identification of participant characteristics that are predictive of attrition might inform retention strategies. Objective The study aimed to identify factors associated with attrition among HIV-infected Russian risky drinkers from the secondary HIV prevention HERMITAGE trial. We examined whether current injection drug use (IDU), binge drinking, depressive symptoms, HIV status nondisclosure, stigma, and lifetime history of incarceration were predictors of study attrition. We also explored effect modification due to gender. Methods Complete loss to follow-up (LTFU), defined as no follow-up visits after baseline, was the primary outcome, and time to first missed visit was the secondary outcome. We used multiple logistic regression models for the primary analysis, and Cox proportional hazards models for the secondary analysis. Results Of 660 participants, 101 (15.3%) did not return after baseline. No significant associations between independent variables and complete LTFU were observed. Current IDU and HIV status nondisclosure were significantly associated with time to first missed visit (adjusted hazard ratio [AHR], 1.39; 95% CI, 1.03–1.87; AHR, 1.38; 95% CI, 1.03–1.86, respectively). Gender stratified analyses suggested a larger impact of binge drinking among men and history of incarceration among women with time to first missed visit. Conclusions Although no factors were significantly associated with complete LTFU, current IDU and HIV status nondisclosure were significantly associated with time to first missed visit in HIV-infected Russian risky drinkers. An understanding of these predictors may inform retention efforts in longitudinal studies.

show abstract

Nondisclosure of HIV Infection to Sex Partners and Alcohol’s Role: A Russian Experience

Cited by 21 publications

References 47 publications

Is cannabis use associated with HIV drug and sex risk behaviors among Russian HIV-infected risky drinkers?

Is cannabis use associated with HIV drug and sex risk behaviors among Russian HIV-infected risky drinkers?

HIV Stigma and Unhealthy Alcohol Use Among People Living with HIV in Russia

Factors Associated With Study Attrition Among HIV-Infected Risky Drinkers in St. Petersburg, Russia

Contact Info

Product

Resources

About